FDA Submission Expected This Summer - Invest Before It Happens

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

EA
Electronic Arts, Inc
NASDAQ
157.08
Open 152.76 Prev Close 152.49
High 157.75 Low 151.50
Volume 4,396,992 Volume (Avg) 3,056
52 Week High 167.85 52 Week Low 114.90
Market Cap 39.5B PE Ratio 39.45

About Electronic Arts, Inc

Electronic Arts Inc. develops, markets, publishes, and delivers games, content, and services for game consoles, PCs, and mobile phones worldwide. It develops and publishes games and services across various genres, such as sports, racing, first-person shooter, action, role-playing, and simulation; and live services offerings, including extra content and subscription offerings through its global football and American football franchises, such as EA SPORTS College Football and EA SPORTS Madden NFL, as well as based on its IP comprising The Sims, Apex Legends, and Battlefield. The company markets and sells its games and services through digital distribution and retail channels; and directly to mass market retailers, specialty stores, and distribution arrangements. Electronic Arts Inc. was incorporated in 1982 and is headquartered in Redwood City, California.

General

NameElectronic Arts, Inc
TickerEA
ExchangeNASDAQ
SectorCommunication Services
IndustryElectronic Gaming & Multimedia
CurrencyUSD
CountryUSA
Fiscal Year EndMarch
Full Time Employees14,500

Highlights

Analyst Target174.25
Market Cap39,469,800,000
PE Ratio39.45
PEG Ratio1.54
EBITDA1,842,000,000

Share Stats

Shares Outstanding251,270,000
Shares Float226,800,000
Shares Short9,460,000
Insider Holdings21%
Institution Holdings105.44%

Highlights

Analyst Target174.25
Market Cap39,469,800,000
PE Ratio39.45
PEG Ratio1.54
EBITDA1,842,000,000

Valuation

Trailing PE39.17
Forward PE18.98
Price/Sales (Trailing 12 Mt.)5.28
Price/Book (Most Recent Quarter)6.49

Dividend

Electronic Arts, Inc pays out a dividend of $0.64 per share, with a dividend yield of 0.41%.

EA's last dividend payment was made to shareholders on June 18, 2025.

They pay out 17.90% of their earnings out as a dividend.

Recent Dividends

Sep 17, 2025$0.19
Jun 18, 2025$0.19
Mar 19, 2025$0.19
Dec 18, 2024$0.19
Sep 18, 2024$0.19
Jun 19, 2024$0.19
Mar 20, 2024$0.19
Dec 20, 2023$0.19
Sep 20, 2023$0.19
Most Popular

Jim Cramer Recommends This 'Really, Really Good' Energy Stock

Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.

Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'

President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Beef: It's What's for Dinner — If You Can Afford It

Here's a look at why beef is the latest item driving grocery bills higher.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Colbert jokes about 'cancel culture' and has a very pointed message for President Donald Trump

Stephen Colbert returned for his first full program after that CBS was canceling his “Late Show” with some supportive late-night guests, a joke about cancel culture and an extremely pointed remark directed at President Donald Trump.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?

Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.

Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad

The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.

Sony's Chipset Unit Up For Sale To Fuel Entertainment Push

Sony is selling its cellular chipset unit as it focuses on entertainment. The unit, acquired for $212M in 2016, could be worth $300M.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch

Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.

Coldplay's jumbotron captures — what exactly? The internet has its theories

LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008

A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

The beauty industry loves argan oil. But demand, and drought, are straining Morocco and its trees

SMIMOU, Morocco (AP) — Argan oil runs through your fingers like liquid gold — hydrating, luscious, and restorative. Prized worldwide as a miracle cosmetic, it’s more than that in Morocco. It’s a lifeline for rural women and a byproduct of a forest slowly buckling under the weight of growing demand.

Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way

New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.

Bessent says child savings accounts in Trump law are 'a back door for privatizing Social Security'

WASHINGTON (AP) — The included in President Donald Trump's “is a back door for privatizing Social Security,” Treasury Secretary Scott Bessent said Wednesday.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Fire is still burning at a Nebraska biofuels plant where explosion left 3 missing

FREMONT, Neb. (AP) — Fire and heavy smoke were still pouring out of a Nebraska biofuels plant Wednesday morning, preventing firefighters from getting close enough to search for a day earlier, officials said.

Kraken Aims To Raise $500 Million, Second-Largest US Crypto Platform Eyeing A $15 Billion Valuation: Report

Cryptocurrency exchange, Kraken, is planning to raise $500 million in funding, a move that could push its valuation to $15 billion, according to a report published Tuesday.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

FOMC Meeting Preview: Will Jerome Powell Accelerate The Bitcoin, Ethereum, XRP Bull Run?

Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Trump's tariffs could squeeze US factories and boost costs by up to 4.5%, a new analysis finds

WASHINGTON (AP) — As President prepares to announce new tariff increases, the costs of his policies are starting to come into focus for a domestic manufacturing sector that depends on global supply chains, with a new analysis suggesting factory costs could increase by roughly 2% to 4.5%.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Edmunds: Five expert tips to make cross-country EV driving easy

The idea of a cross-country road trip in an electric vehicle might seem daunting. After all, it’s not hard to envision getting stranded on the side of the road with a depleted battery or being stuck in a parking lot, charging for hours. But there are ways to easily avoid these worst-case scenarios. The experts at Edmunds have plenty of experience driving electric vehicles, and here they share their five best tips on how to make cross-country driving in an EV easy.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service